Accumax Lab Devices Profile
Key Indicators
- Authorised Capital ₹ 15.50 Cr
as on 06-10-2024
- Paid Up Capital ₹ 11.05 Cr
as on 06-10-2024
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 161.32 Cr
as on 06-10-2024
- Satisfied Charges ₹ 18.99 Cr
as on 06-10-2024
- Revenue 125.15%
(FY 2022)
- Profit 159.06%
(FY 2022)
- Ebitda 117.79%
(FY 2022)
- Net Worth 68.05%
(FY 2022)
- Total Assets 95.30%
(FY 2022)
About Accumax Lab Devices
The Corporate was formerly known as Finecare Enterprises Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 15.50 Cr and a paid-up capital of Rs 11.05 Cr.
The company currently has active open charges totaling ₹161.32 Cr. The company has closed loans amounting to ₹18.99 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Accumax Lab Devices Private Limited India is Neha Singh as COMPANY SECRETARY. Buggana Hariharnath, Bhupendra Shah, Tejas Shah, and Five other members serve as directors at the Company.
- CIN/LLPIN
U33110GJ2009PTC056957
- Company No.
056957
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 May 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Accumax Lab Devices?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chirag Shah  | Managing Director | 15-May-2009 | Current |
| Neha Singh | Company Secretary | 01-Apr-2022 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nirali Shah | Director | 15-May-2009 | Current |
Buggana Hariharnath  | Additional Director | 04-Oct-2024 | Current |
| Bhupendra Shah | Director | 15-May-2009 | Current |
| Tejas Shah | Director | 15-May-2009 | Current |
| Deshal Shah | Director | 01-Aug-2018 | Current |
| Kabir Thakur | Nominee Director | 21-Aug-2024 | Current |
Financial Performance and Corporate Structure Insights of Accumax Lab Devices.
Accumax Lab Devices Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 125.15% increase. The company also saw a substantial improvement in profitability, with a 159.06% increase in profit. The company's net worth Soared by an impressive increase of 68.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Accumax Lab Devices?
In 2023, Accumax Lab Devices had a promoter holding of 79.66% and a public holding of 20.34%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 21 Jul 2018 | ₹161.32 Cr | Open |
Axis Bank Limited Creation Date: 06 Oct 2020 | ₹1.09 Cr | Satisfied |
Axis Bank Limited Creation Date: 21 Jul 2018 | ₹3.81 Cr | Satisfied |
How Many Employees Work at Accumax Lab Devices?
Accumax Lab Devices has a workforce of 822 employees as of Oct 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Accumax Lab Devices, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Accumax Lab Devices's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
